Lunch Session Sponsored by AstraZeneca

12:30-14:00   Wednesday, 25 April, 2018
Lunch Session Sponsored by AstraZeneca - Hall I - Zefat
DAPT Beyond One Year in High Risk Patients Post MI
Chair: Prof. Rozenman Yoseph
 
 Time TopicSpeaker
12:45-12:55Opening and Case PresentationProf. Rozenman Yoseph
12:55-13:15Cons: High Risk Patients Post MI Should Not Continue DAPT beyond a year Prof. Eli Lev
13:15-13:35Pros: High Risk Patients Post MI Need Continuous DAPT Beyond a Year Prof. Gabriel Steg
13:35-13:45Panel DiscussionChairman: Prof. Yoseph Rozenman
Panel members: Prof. Gabriel Steg,
Prof. Eli Lev


To Register Click Here